Tumor-released survivin induces a type-2 T cell response and decreases cytotoxic T cell function, in vitro

Cancer Microenvironment

Volumn 6, Issue 1, 2013, Pages 57-68

  Jutzy, Jessica M S ^a   Khan, Salma ^a   Asuncion Valenzuela, Malyn May ^a   Milford, Terry Ann M ^a   Payne, Kimberly J ^a   Wall, Nathan R ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Microenvironment; Survivin; T cell; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; SURVIVIN;

ARTICLE; CANCER CELL; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

EID: 84875276891     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-012-0096-9     Document Type: Article

References (55)

1. J Riemensberger A Bohle S Brandau 2002 IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer Clin Exp Immunol 127 20 26 11882028 10.1046/j.1365-2249.2002. 01734.x 1:CAS:528:DC%2BD38Xit1WmtL4%3D
2. DL Woodland RW Dutton 2003 Heterogeneity of CD4+ and CD8+ T cells Curr Opin Immunol 15 336 342 12787761 10.1016/S0952-7915(03)00037-2 1:CAS:528:DC%2BD3sXkt1KntL0%3D
3. J Zhu WE Paul 2008 CD4 T cells: fates, functions and faults Blood 112 5 1557 1563 18725574 10.1182/blood-2008-05-078154 1:CAS:528:DC%2BD1cXhtVylurbK
4. DF Fiorentino A Zlotnik P Vieira TR Mosmann M Howard KW Moore A O'Garra 1991 IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 3444 3451 1827484 1:CAS:528:DyaK3MXltleksLg%3D
5. O Wurtz M Bajenoff S Guerder 2004 IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms Int Immunol 16 3 501 508 14978023 10.1093/intimm/dxh050 1:CAS:528:DC%2BD2cXhs12ktbo%3D
6. DG DeNardo JB Barreto P Andreu L Vasquez D Tawfik N Kolhatkar LM Coussens 2009 CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages Cancer Cell 16 2 91 102 19647220 10.1016/j.ccr.2009.06.018 1:CAS:528:DC%2BD1MXhsVCjsrfJ
7. XO Yang B Pappu R Nurieva A Akimzhanov HS Kang Y Chung L Ma B Shah AD Panopoulos K Schluns SS Watowich Q Tian AM Jetten C Dong 2008 TH17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and RORgamma Immunity 28 1 29 39 18164222 10.1016/j.immuni.2007.11.016 1:CAS:528: DC%2BD1cXht1Ontrs%3D
8. SC Liang XY Tan DP Luxenberg R Karim K Dunussi-Joannopoulos M Collins LA Fouser 2006 Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J Exp Med 203 10 2271 2279 16982811 10.1084/jem.20061308 1:CAS:528:DC%2BD28XhtVGls7fF
9. Y Liao D Schaue WH McBride 2007 Modification of the tumor microenvironment to enhance immunity Front Biosci 12 3576 3600 17485323 10.2741/2336 1:CAS:528:DC%2BD2sXms1Kmtb0%3D
10. K Chikamatsu K Sakakura TL Whiteside N Furuya 2007 Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck Head & Neck 29 120 127 10.1002/hed.20490
11. SL Clarke GJ Betts A Plant KL Wright TM El-Shanawany R Harrop J Torkington BI Rees GT Williams AM Gallimore AJ Godkin 2006 CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer PLoS One 1 1 e129 17205133 10.1371/journal.pone.0000129
12. W Liu AL Putnam Z Xu-Yu GL Szot MR Lee S Zhu PA Gottlieb P Kapranov TR Gingeras F de St B Groth C Clayberger DM Soper SF Ziegler JA Bluestone 2006 CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells J Exp Med 203 7 1701 1711 16818678 10.1084/jem.20060772 1:CAS:528:DC%2BD28XntVCgs70%3D
13. K Ehi S Ishigami I Masamoto Y Uenosono S Natsugoe T Arigami H Arima Y Kijima H Yoshinaka S Yanagita T Kozono Y Funasako I Maruyama T Aikou 2008 Analysis of T-helper type1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer Oncol Rep 19 601 607 18288390
14. X Filella J Alcover MA Zarco P Beardo R Molina AM Ballesta 2000 Analysis of type T1 and T2 cyokines in patients with prostate cancer Prostate 44 271 275 10951490 10.1002/1097-0045(20000901)44:4<271::AID-PROS2>3.0.CO;2-G 1:CAS:528:DC%2BD3cXmsF2gsbo%3D
15. N Ito H Nakamura H Netsugi Ohgi 2001 Dissociation between T helper type 1 and type 2 differentiation and cytokine produciton in tumor-infiltrating lymphocytes in pateints with lung cancer Surgery Today 31 390 394 11381500 10.1007/s005950170127 1:CAS:528:DC%2BD3MXltV2hu74%3D
16. T Mainou-Fowler PRA Taylor S Miller AM Dickinson SJ Proctor 2003 Intracellular cytokine profiles by peripheral blood CD3+ T-cells in patients with classical Hodgkin lymphoma Leukemia & Lymphoma 44 8 1331 10.1080/1042819031000090246
17. H Nakayama J Kitayama T Muto H Nagawa 2000 Characterization of intracellular cytokine profile of CD4+ T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer Jpn J Clin Oncol 30 7 301 305 11007162 10.1093/jjco/hyd078 1:STN:280:DC%2BD3cvltFCktg%3D%3D
18. S Schreck D Briebel M Buettner L Distel G Grabenbauer LS Young G Niedobitek 2009 Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma Hematol Oncol 27 31 39 18924115 10.1002/hon.878 1:CAS:528:DC%2BD1MXkvVGqtLw%3D
19. H Ubukata G Motohashi T Tabuchi H Nagata S Konishi T Tabuchi 2010 Evaluations of inteferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients J Surg Oncol 102 742 747 20872813 10.1002/jso.21725
20. L De Monte M Reni E Tassi D Clavenna I Papa H Recalde M Braga V Di Carlo C Doglioni MP Protti 2011 Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer J Exp Med 208 3 469 478 21339327 10.1084/jem.20101876
21. A Sharma R Khan S Joshi L Kumar M Sharma 2010 Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma Leukemia & Lymphoma 51 5 920 927 10.3109/10428191003699563 1:CAS:528:DC%2BC3cXltlWitLg%3D
22. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sorlie T, Warnberg F, Haakensen VD, Helland A, Naume B, Perou CM, Haussler D, Troyanskaya OG, Borresen-Dale AL (2011) Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. PNAS 10
23. A Naldini A Pucci C Bernini F Carraro 2003 Regulation of angiogenesis by Th1 and Th2 type cytokines Curr Pharm Des 9 511 519 12570799 10.2174/1381612033391423 1:CAS:528:DC%2BD3sXhsVOhsrc%3D
24. H Murakami H Ogawara H Hiroshi 2004 Th1/Th2 cells in patients with multiple myeloma Hematology 9 1 41 46 14965867 10.1080/10245330310001652437 1:CAS:528:DC%2BD2cXhtFCltrc%3D
25. A Sellitto G Galizia U De Fanis E Lieto A Zamboli M Orditura F De Vita R Giunta G Lucivero C Romano 2011 Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery J Clin Immunol 31 1095 1104 21915633 10.1007/s10875-011-9585-8 1:CAS:528:DC%2BC3MXhsFCitrjI
26. Wang Z, Yang B, Liu H, Hu Y, Yang J, Wu L, Zhou Z, Jiao S (2011) Regulatory T cells increase in breast cancer and in stage IV breast cancer. Cancer Immunology, Immunotherapy
27. W Yamagami N Susumu H Tanaka A HIrasawa K Banno N Suzuki H Tsuda K Tsukazaki D Aoki 2011 Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer Int J Gynecol Canc 21 1628 1634 10.1097/IGC.0b013e31822c271f
28. I Kryczek M Banerjee P Cheng L Vatan W Szeliga S Wei E Huang E Finlayson D Simeone TH Welling A Chang G Coukos R Liu W Zou 2009 Phenotype, distribution, generation and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 1141 1149 19470694 10.1182/blood-2009-03-208249 1:CAS:528:DC%2BD1MXhtVSgsbbE
29. KS Sfanos TC Burno CH Maris L Xu CJ Thoburn AM DeMarzo AK Meeker WB Isaacs CG Drake 2008 Phenotypic analysis of prostate-infiltrating lymphocytes reveals Th17 and Treg skewing Clin Cancer Res 14 11 3254 3261 18519750 10.1158/1078-0432.CCR-07-5164 1:CAS:528:DC%2BD1cXmslygs70%3D
30. I Kryczek S Wei W Szeliga L Vatan W Zou 2009 Endogenous IL-17 contributes to reduced tumor growth and metastasis Blood 114 357 359 19289853 10.1182/blood-2008-09-177360 1:CAS:528:DC%2BD1MXovVKlsr0%3D
31. C Li Y Zhao W Zhang W Zhang 2011 Increased prevalence of TH17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 1 80 89
32. TL Whiteside 2008 The tumor microenvironment and its role in promoting tumor growth Oncogene 27 2904 2912 10.1038/onc.2008.271
33. H Zhang WE Grizzle 2011 Exosomes and cancer: a newly described pathway of immune suppression Clin Cancer Res 17 959 964 21224375 10.1158/1078-0432.CCR- 10-1489 1:CAS:528:DC%2BC3MXis1eit7o%3D
34. S Khan JR Aspe MG Asumen F Almaguel O Odumosu S Acevedo-Martinez M De Leon WH Langridge NR Wall 2009 Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential Br J Cancer 100 7 1073 1086 19293795 10.1038/sj.bjc.6604978 1:CAS:528:DC%2BD1MXktVGksbY%3D
35. S Khan JMS Jutzy JR Aspe DW McGregor JW Neidigh NR Wall 2011 Survivin is released from cancer cells via exosomes Apoptosis 16 1 1 12 20717727 10.1007/s10495-010-0534-4 1:CAS:528:DC%2BC3MXpvVCnsA%3D%3D
36. C Adida PL Crotty J McGrath D Berrebi J Diebold DC Altieri 1998 Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 152 43 49 9422522 1:CAS:528:DyaK1cXktlygtA%3D%3D
37. T Dohi E Beltrami NR Wall J Plescia DC Altieri 2004 Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis J Clin Invest 114 1117 1127 15489959 1:CAS:528:DC%2BD2cXovVensrc%3D
38. T Scholzen J Gerdes 2000 The Ki-67 protein: from the known and the unknown J Cell Physiol 182 3 311 322 10653597 10.1002/(SICI)1097-4652(200003) 182:3<311::AID-JCP1>3.0.CO;2-9 1:CAS:528:DC%2BD3cXot1Ggsg%3D%3D
39. AB Lyons CR Parish 1994 Determination of lymphocyte division by flow cytometry J Immunol Methods 171 1 131 137 8176234 10.1016/0022-1759(94)90236-4 1:STN:280:DyaK2c3jtFSjsw%3D%3D
40. J Song T So M Cheng X Tang M Croft 2005 Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion Immuunity 22 621 631 10.1016/j.immuni.2005.03.012 1:CAS:528:DC%2BD2MXkslOqsbc%3D
41. Morris J, Waldmann T (2000) Advances in interleukin 2 receptor targeted treatment. Annals of the Rheumatic Diseases Suppl 1:I109-114
42. X Ke J Wang L Li IH Chen H Wang XF Yang 2008 Roles of CD4+CD25high Foxp3+ Tregs in lymphomas and tumors are complex Front Biosci 13 2986 3001
43. N Manel D Unutmaz DR Littman 2008 The differentiation of human Th17 cells requires transforming growth factor beta and induction of the nuclear receptor RORγt Nat Immunol 9 6 641 649 18454151 10.1038/ni.1610 1:CAS:528:DC%2BD1cXmtVWqurg%3D
44. S Mera M Magnusson A Tarkowski M Bokarewa 2008 Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern J Leukoc Biol 83 149 154 17938276 10.1189/jlb.0507287 1:CAS:528:DC%2BD1cXks1Sqsw%3D%3D
45. Chattopadhyay S, Mehrortra S, Chhabra A, Hegde U, Mukherji B, Chakraborty NG (2006) Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro. J Immunol 176(2)
46. E James A Yeh C King F Korangy I Bailey DS Boulanger BJ Van den Eynde N Murray TJ Elliott 2010 Differential suppression of tumor-specific CD8+ T cells by regulatory T cells J Immunol 185 9 5048 5055 20921533 10.4049/jimmunol. 1000134 1:CAS:528:DC%2BC3cXhtlWhsr%2FI
47. S Koyama N Koike S Adachi 2002 Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor J Cancer Res Clin Oncol 128 73 80 11862476 10.1007/s004320100292 1:CAS:528:DC%2BD38XjvFCksw%3D%3D
48. S Koyama N Koike S Adachi 2001 Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma J Cancer Res Clin Oncol 127 20 26 11206267 10.1007/s004320000181 1:CAS:528:DC%2BD3MXitVOrsA%3D%3D
49. JI Ellyard L Simson CR Parish 2007 Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 70 1 11 17559575 10.1111/j.1399-0039.2007.00869.x 1:CAS:528:DC%2BD2sXosFejtbo%3D
50. A Hamai H Benlalam F Meslin M Hasmim T Carre I Akalay B Janji G Berchem MZ Noman S Chouaib 2010 Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumor system call the tune? Tissue Antigens 75 1 8 20196816 10.1111/j.1399-0039.2009.01401.x 1:CAS:528: DC%2BC3cXht1KhsrY%3D
51. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunology, Immunotherapy Epub (Epub):e1-e6
52. E Maniati R Soper T Hagemann 2010 Up for Mischief? IL-17/Th17 in the tumour microenviroment Oncogene 29 42 5653 5662 20729908 10.1038/onc.2010.367 1:CAS:528:DC%2BC3cXhtVGgtLbF
53. ZZ Yang AJ Novak SC Ziesmer TE Witzig SM Ansell 2009 Malignant B cells skew the balance of regulatory T cells and Th17 cells in B-cell non-Hodgkin's lymphoma Cancer Res 69 13 5522 5530 19509224 10.1158/0008-5472.CAN-09-0266 1:CAS:528:DC%2BD1MXnvFajs7g%3D
54. J Liu Y Duan X Cheng X Chen W Xie H Long Z Lin B Zhu 2011 IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma Biochem Biophys Res Commun 407 2 348 354 21396350 10.1016/j.bbrc.2011.03.021 1:CAS:528:DC%2BC3MXks1Wmsrk%3D
55. T Jung U Schauer C Heusser C Neumann C Rieger 1993 Detection of intracellular cytokines by flow cytometry J Immunol Methods 159 1-2 197 207 8445253 10.1016/0022-1759(93)90158-4 1:CAS:528:DyaK3sXktVKlurY%3D